The renaissance of antibody therapy

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 3, 1998, Pages 319-322

  Burnie, James P ^a   Matthews, Ruth C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

BACTERIAL INFECTION; SHORT SURVEY;

ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOTHERAPY; INFECTION;

EID: 0031896545     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.3.319     Document Type: Short Survey

References (29)

1. Casadevall, A. & Scharff, M. D. (1995). Return to the past: the case for antibody-based therapies in infectious diseases. Clinical Infectious Diseases 21,150-61.
2. WHO Scientific Working Group. (1994). Monitoring and management of bacterial resistance to antimicrobial agents, report WHO/CDS/BVI, 95-97 (Martinez, L, Ed.). WHO, Geneva.
3. Weinstein, J. W., Roe, M., Towns, M., Sanders, L., Thorpe, J. J., Corey, G. R. & Sexton, D. J. (1996). Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infection Control and Hospital Epidemiology 17, 36-41.
4. Ayliffe, G. A. (1997). The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 24, Suppl. 1, S74-9.
5. Thomas, A., Cheasty, T., Frost, J. A., Chart, H., Smith, H. R. & Rowe, B. (1996). Verocytoxin-producing Escherichia coli, particularly serogroup 0157, associated with human infections in England and Wales: 1992-4. Epidemiology and Infection 117, 1-10.
6. Spencer, R. C. (1995). The emergence of epidemic, multiple-antibiotic-resistant Strenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. Journal of Hospital Infection 30, Suppl., 453-64.
7. Harvey, R. L. & Myers, J. P. (1987). Nosocomial fungemia in a large community teaching hospital. Archives of Internal Medicine 147, 2117-20.
8. Kohler, G. & Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-7.
9. Wright, A., Shin, S. U. & Morrison, S. L. (1992). Genetically engineered antibodies: progress and prospects. Critical Reviews in Immunology 12,125-68.
10. Ward, E. S. & Ghetie, V. (1995). The effector functions of immunoglobulins: implications for therapy. Therapeutic Immunology 2, 77-94.
11. Jespers, L. S., Roberts, A., Mahler, S. M., Winter, G. & Hoogenboom, H. R. (1994). Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biotechnology 12, 899-903.
12. Matthews, R. C., Burnie, J. P. & Tabaqchali, S. (1984). Immunoblot analysis of the serological response in systemic candidosis. Lancet ii, 1415-8.
13. Emsley, P., Charles, I. G., Fairweather, N. F. & Isaacs, N. W. (1996). Structure of Bordetella pertussis virulence factor P.69 pertactin. Nature 381, 90-2.
14. Steward, M. W., Stanley, C. M. & Obeid, O. E. (1995). A mimotope from a solid-phase peptide library induces a measles virus-neutralising and protective antibody response. Journal of Virology 69, 7668-73.
15. Valadon, P., Nussbaum, G., Boyd, L. F., Margulies, D. H. & Scharff, M. D. (1996). Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. Journal of Molecular Biology 261, 11-22.
16. Tribbick, G., Triantafyllou, B., Lauricella, R., Rodda, S. J., Mason, T. J. & Geysen, H. M. (1991). Systematic fractionation of serum antibodies using multiple antigen homologous peptides as affinity ligands. Journal of Immunological Methods 139, 155-66.
17. Cane, P. A. (1997). Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus. Journal of Medical Virology 51, 297-304.
18. Shankar, P., Fabry, J. A., Fong, D. M. & Lieberman, J. (1996). Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. Immunology Letters 52, 23-30.
19. Burnie, J. P., Brooks, W., Donohoe, M., Hodgetts, S., Al-Ghamdi, A. & Matthews, R. C. (1996). Defining antibody targets in Streptococcus oralis infection. Infection and Immunity 64, 1600-8.
20. Zheng, X., Lau, K., Frazier, M., Cassell, G. H. & Watson, H. L. (1996). Epitope mapping of the variable repetitive region with the MB antigen of Ureaplasma urealyticum. Clinical and Diagnostic Laboratory Immunology 3, 774-8.
21. Bockenstedt, L. K., Fikrig, E., Barthold, S. W., Flavell, R. A. & Kantor, F. S. (1996). Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice. Journal of Immunology 157, 5496-502.
22. Matthews, R. C., Burnie, J. P., Howat, D., Rowland, T. & Walton, F. (1991). Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology 74, 20-4.
23. Zhang, H., Zhong, Z. & Pirofski, L. A. (1997). Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody. Infection and Immunity 65, 1158-64.
24. Soto, M., Requena, J. M., Quijada, L., Garcia, M., Guzman, F., Patarroyo, M. E. et al. (1995). Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunology 48, 209-14.
25. Matthews, R. C., Hodgetts, S. & Burnie, J. P. (1995). Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. Journal of Infectious Diseases 171, 1668-71.
26. Johnson, S., Sypura, W. D., Gerding, D. N., Ewing, S. L. & Janoff, E. N. (1995). Selective neutralization of a bacterial enterotoxin by serum immunoglobulin in response to mucosal disease. Infection and Immunity 63, 3166-73.
27. Warny, M., Denie, C., Delmee, M. & Lefebvre, C. (1995). Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A. Acta Clinica Belgica 50, 36-9.
28. Welch, P. G., Fattom, A., Moore, J., Schneerson, R., Shiloach, J., Bryla, D. A., Li, X. & Robbins, J. B. (1996). Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprolein A conjugate vaccine in patients on hemodialysis. Journal of the American Society of Nephrology 7, 247-53.
29. Krause, R. M., Dimmock, N. J. & Morens, D. M. (1997). Summary of antibody workshop: the role of humoral immunity in the treatment and prevention of emerging and extant infectious diseases. Journal of Infectious Diseases 176, 549-59.